Summary
When considered comprehensively, 30% of children treated with growing instrumentation to manage early onset scoliosis have one or more unplanned returns to the operating room.
This is a preview of subscription content, log in via an institution to check access.
Author information
Consortia
Additional information
Author disclosures: Jason Anari: none. John Flynn: Biomet; Lippincott Willimas & Wilkins; Wolters Kluwer Health. Michael Vitale: Childrens Spine Foundation; IPOS; Pediatric Orthopaedic Society of North America; SSG; Medtronic Sofamor Danek; Stryker; Wellinks; Biomet; CSSG, Scoliosis Research Society, OSRF; DePuy; DePuy, A Johnson & Johnson Company; FOX; Medtronic; OMEGA; Synthes. John Smith: Chest Wall and Spine Deformity Research Foundation; Children’s Spine Foundation; Biomet; DePuy Synthes; Depuy Synthes, Spine; Ellipse Technologies; Globus Medical; Spinegaurd; Synthes; VEPTR 2. Jaime A. Gomez: none. Children’s Spine Study Group: DePuy Synthes Research Grant.
Rights and permissions
About this article
Cite this article
Anari, J., Flynn, J., Vitale, M. et al. Paper #22: Unplanned Return to OR for EOS Children: A Comprehensive Evaluation of all Diagnoses and Instrumentation Strategies. Spine Deform 5, 450–451 (2017). https://doi.org/10.1016/j.jspd.2017.09.025
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jspd.2017.09.025